Official UK procurement notice
DSIT & NI Project Barbara PoC
Authority: Department for Science, Innovation & Technology (Central government)
What is being bought
Published requirement descriptionThe Dementia Goals programme (DGP), part of the Healthcare Goals programme (based in the Office for Life Sciences within DSIT).
The Dame Barbara Windsor Dementia Goals programme, , aims to speed up the development of new treatments for dementia by accelerating innovations in biomarkers, clinical trials and implementation.
This project is to undertake a Proof of Concept (PoC) study to test the feasibility of BARBARA - a Brain Ageing Registry for Biomarkers, Access to trials, Research, and Adoption.
The lotProcurement structure
single lot · no lot value publishedProcedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 22 Apr 2026, 09:11 BST
- Last source update
- 22 Apr 2026, 09:11 BST
- Authority reference
prj_6753- FTS notice number
2026/S 000-036392- Latest notice
- Transparency notice (UK5)
- Delivery area
- Official registry OCID
ocds-h6vhtk-068808Find a Tender
- Why no open competition
- Prototypes Development; Single Suppliers Technical Reasons
- Published justification
DSIT (OLS) proposes awarding a twelve-month research and development contract to the Neurodegeneration Initiative’ (NI) to carry out a proof-of-concept feasibility study which will lead to creation of the Project BARBARA platform, as an exempted contract under Schedule 2, paragraph 22 of the Procurement Act 2023.
The R&D services exemption under Schedule 2 paragraph 22 gives contracting authorities the freedom to design R&D programs that could seek to develop products or technology for the benefit of the market as a whole, and for which the authority itself has no requirements. For example, government contracts for research by public research institutions, universities or the private sector.
The exemption, at Schedule 2 paragraph 22(1), applies where the services to be procured are intended by the contracting authority to be for a public benefit or result in a public benefit. This is satisfied because the purpose of the contract and services is to create a platform that will benefit the public - solely for the supply of R&D services; this is also satisfied.
The services must also consist of one or more of the activities listed in paragraph 22(2) (a)-(d). The most relevant of these is paragraph 22(2)(c):
“(c) development which uses existing knowledge to initiate the manufacture of new materials or products, establish new processes, systems or services, or to achieve a substantial improvement in existing materials, products, processes, systems or services"
Notice history
2 events · 1 release on Find a Tender · since 22 Apr 2026- Transparency notice published22 Apr 2026, 09:11 BSTUK5
- Contract signature expected22 Apr 2026, 23:59 BSTscheduled
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Neurodegeneration Initiative LtdVCSE22 Apr 2026 – 31 Mar 2027 | £2,750,000 | — | Standstill |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Neurodegeneration Initiative LtdAwarded supplier
Official documents & specifications (1)
Official links; attachments are not copiedNotices published for this procedure
- Transparency notice Transparency notice on Find a Tender